The use of cyclazocine in treating narcotic addicts in a low-intervention setting.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D001294:Attitude to Health; D003248:Constipation / Q000139:chemically induced; D003496:Cyclazocine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006261:Headache / Q000139:chemically induced; D006556:Heroin Dependence / Q000188:drug therapy / Q000534:rehabilitation / Q000628:therapy*; D006801:Humans; D008297:Male; D009270:Naloxone / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D010044:Outpatient Clinics, Hospital; D010352:Patient Dropouts; D010551:Personality; D011581:Psychological Tests; D014717:Vertigo / Q000139:chemically induced
D009270:Naloxone; D003496:Cyclazocine